Confirmatory cross-sectional validation of the Asthma Impairment and Risk Questionnaire

Affiliations

¹ Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Md. Electronic address: rwise@jhmi.edu.
² Capital Allergy and Respiratory Disease Center, Sacramento, Calif.
³ Boys Town National Research Hospital, Boys Town, Neb.
⁴ National Jewish Health, Denver, Colo.
⁵ New York University School of Medicine, New York, NY.
⁶ Allergy Partners, Asheville, NC.
⁷ AstraZeneca, Wilmington, Del.
⁸ Evidera, Bethesda, Md.
⁹ Columbia University School of Nursing, New York, NY.
¹⁰ Department of Allergy, Kaiser Permanente Southern California, San Diego, Calif; Department of Research and Evaluation, Kaiser Permanente Southern California, San Diego, Calif; Department of Clinical Science, Bernard J. Tyson School of Medicine, Pasadena, Calif.

Free article

Robert A Wise et al. J Allergy Clin Immunol Pract. 2023 Nov.

Free article

. 2023 Nov;11(11):3531-3533.e1.

doi: 10.1016/j.jaip.2023.07.018. Epub 2023 Jul 19.

¹ Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Md. Electronic address: rwise@jhmi.edu.
² Capital Allergy and Respiratory Disease Center, Sacramento, Calif.
³ Boys Town National Research Hospital, Boys Town, Neb.
⁴ National Jewish Health, Denver, Colo.
⁵ New York University School of Medicine, New York, NY.
⁶ Allergy Partners, Asheville, NC.
⁷ AstraZeneca, Wilmington, Del.
⁸ Evidera, Bethesda, Md.
⁹ Columbia University School of Nursing, New York, NY.
¹⁰ Department of Allergy, Kaiser Permanente Southern California, San Diego, Calif; Department of Research and Evaluation, Kaiser Permanente Southern California, San Diego, Calif; Department of Clinical Science, Bernard J. Tyson School of Medicine, Pasadena, Calif.

No abstract available

Publication types